Page last updated: 2024-10-23

bencyclane and Bradycardia

bencyclane has been researched along with Bradycardia in 2 studies

Bencyclane: A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.

Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Széplaki, S2
Széplaki, Z1

Trials

1 trial available for bencyclane and Bradycardia

ArticleYear
[Prolonged bencyclane (Halidor) therapy of symptomatic sinus bradycardia, sick sinus syndrome and atrioventricular block].
    Orvosi hetilap, 1979, Sep-02, Volume: 120, Issue:35

    Topics: Aged; Bencyclane; Bradycardia; Clinical Trials as Topic; Cycloheptanes; Female; Heart Block; Humans;

1979

Other Studies

1 other study available for bencyclane and Bradycardia

ArticleYear
[Fludilat treatment of vagotonic and subendocardial disturbances of cardiac metabolism and bradycardiac coronary diseases (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1976, Mar-05, Volume: 118, Issue:10

    Topics: Acute Disease; Adult; Aged; Bencyclane; Bradycardia; Chronic Disease; Coronary Circulation; Coronary

1976